When amyloids become prions

References

• Chiti F, Dobson CM. Protein misfolding, functional amyloid, and human disease. Annu Rev Biochem 2006; 75:333-66; PMID: 16756495; http://dx.doi.org/10.1146/annurev.biochem.75.101304.123901
   PubMed Web of Science ®Google Scholar
• Byers AL, Yaffe K. Depression and risk of developing dementia. Nat Rev Neurol 2011; 7:323-31; PMID: 21537355; http://dx.doi.org/10.1038/nrneurol.2011.60
   PubMed Web of Science ®Google Scholar
• Porzoor A, Macreadie IG. Application of Yeast to Study the Tau and Amyloid-beta Abnormalities of Alzheimer's Disease. J Alzheimers Dis 2013; 35:217-25; PMID: 23396350
   PubMed Web of Science ®Google Scholar
• Reitz C, Brayne C, Mayeux R. Epidemiology of Alzheimer disease. Nat Rev Neurol 2011; 7:137-52; PMID: 21304480; http://dx.doi.org/10.1038/nrneurol.2011.2
   PubMed Web of Science ®Google Scholar
• Carulla N, Caddy GL, Hall DR, Zurdo J, Gairi M, Feliz M, Giralt E, Robinson CV, Dobson CM. Molecular recycling within amyloid fibrils. Nature 2005; 436:554-8; PMID: 16049488; http://dx.doi.org/10.1038/nature03986
   PubMed Web of Science ®Google Scholar
• Kodali R, Wetzel R. Polymorphism in the intermediates and products of amyloid assembly. Curr Opin Struct Biol 2007; 17:48-57; PMID: 17251001; http://dx.doi.org/10.1016/j.sbi.2007.01.007
   PubMed Web of Science ®Google Scholar
• de Groot NS, Sabate R, Ventura S. Amyloids in bacterial inclusion bodies. Trends Biochem Sci 2009; 34:408-16; PMID: 19647433; http://dx.doi.org/10.1016/j.tibs.2009.03.009
   PubMed Web of Science ®Google Scholar
• Wang L, Maji SK, Sawaya MR, Eisenberg D, Riek R. Bacterial inclusion bodies contain amyloid-like structure. PLoS Biol 2008; 6:e195; PMID: 18684013; http://dx.doi.org/10.1371/journal.pbio.0060195
   PubMed Web of Science ®Google Scholar
• Villar-Pique A, Sabate R, Lopera O, Gibert J, Torne JM, Santos M, Ventura S. Amyloid-like protein inclusions in tobacco transgenic plants. PLoS One 2010; 5:e13625; PMID: 21049018; http://dx.doi.org/10.1371/journal.pone.0013625
   PubMedGoogle Scholar
• Rousseau F, Schymkowitz J, Serrano L. Protein aggregation and amyloidosis: confusion of the kinds? Curr Opin Struct Biol 2006; 16:118-26; PMID: 16434184; http://dx.doi.org/10.1016/j.sbi.2006.01.011
   PubMed Web of Science ®Google Scholar
• Aguzzi A, Calella AM. Prions: protein aggregation and infectious diseases. Physiol Rev 2009; 89:1105-52; PMID: 19789378; http://dx.doi.org/10.1152/physrev.00006.2009
   PubMed Web of Science ®Google Scholar
• Chien P, Weissman JS, DePace AH. Emerging principles of conformation-based prion inheritance. Annu Rev Biochem 2004; 73:617-56; PMID: 15189155; http://dx.doi.org/10.1146/annurev.biochem.72.121801.161837
   PubMed Web of Science ®Google Scholar
• Soto C. Transmissible proteins: expanding the prion heresy. Cell 2012; 149:968-77; PMID: 22632966; http://dx.doi.org/10.1016/j.cell.2012.05.007
   PubMed Web of Science ®Google Scholar
• Colby DW, Prusiner SB. De novo generation of prion strains. Nat Rev Microbiol 2011; 9:771-7; PMID:21947062; http://dx.doi.org/10.1038/nrmicro2650
   PubMed Web of Science ®Google Scholar
• Liu L, Drouet V, Wu JW, Witter MP, Small SA, Clelland C, Duff K. Trans-synaptic spread of tau pathology in vivo. PLoS One 2012; 7:e31302; PMID: 22312444; http://dx.doi.org/10.1371/journal.pone.0031302
   PubMed Web of Science ®Google Scholar
• de Calignon A, Polydoro M, Suarez-Calvet M, William C, Adamowicz DH, Kopeikina KJ, Pitstick R, Sahara N, Ashe KH, Carlson GA, et al. Propagation of tau pathology in a model of early Alzheimer's disease. Neuron 2012; 73:685-97; PMID: 22365544; http://dx.doi.org/10.1016/j.neuron.2011.11.033
   PubMed Web of Science ®Google Scholar
• Caughey B, Baron GS, Chesebro B, Jeffrey M. Getting a grip on prions: oligomers, amyloids, and pathological membrane interactions. Annu Rev Biochem 2009; 78:177-204; PMID: 19231987; http://dx.doi.org/10.1146/annurev.biochem.78.082907.145410
   PubMed Web of Science ®Google Scholar
• Lee SJ, Desplats P, Sigurdson C, Tsigelny I, Masliah E. Cell-to-cell transmission of non-prion protein aggregates. Nat Rev Neurol 2010; 6:702-6; PMID: 21045796; http://dx.doi.org/10.1038/nrneurol.2010.145
   PubMed Web of Science ®Google Scholar
• Brundin P, Melki R, Kopito R. Prion-like transmission of protein aggregates in neurodegenerative diseases. Nat Rev Mol Cell Biol 2010; 11:301-7; PMID: 20308987; http://dx.doi.org/10.1038/nrm2873
   PubMed Web of Science ®Google Scholar
• Jucker M, Walker LC. Pathogenic protein seeding in Alzheimer disease and other neurodegenerative disorders. Ann Neurol 2011; 70:532-40; PMID: 22028219; http://dx.doi.org/10.1002/ana.22615
   PubMed Web of Science ®Google Scholar
• Eisele YS, Obermuller U, Heilbronner G, Baumann F, Kaeser SA, Wolburg H, Walker LC, Staufenbiel M, Heikenwalder M, Jucker M. Peripherally applied Abeta-containing inoculates induce cerebral beta-amyloidosis. Science 2010; 330:980-2; PMID: 20966215; http://dx.doi.org/10.1126/science.1194516
   PubMed Web of Science ®Google Scholar
• Brown P, Rau EH, Johnson BK, Bacote AE, Gibbs CJ, Jr., Gajdusek DC. New studies on the heat resistance of hamster-adapted scrapie agent: threshold survival after ashing at 600 degrees C suggests an inorganic template of replication. Proc Natl Acad Sci U S A 2000; 97:3418-21; PMID: 10716712
   PubMed Web of Science ®Google Scholar
• McKinley MP, Bolton DC, Prusiner SB. A protease-resistant protein is a structural component of the scrapie prion. Cell 1983; 35:57-62; PMID: 6414721; http://dx.doi.org/10.1016/0092-8674(83)90207-6
   PubMed Web of Science ®Google Scholar
• Soto C. Prion hypothesis: the end of the controversy? Trends Biochem Sci 2011; 36:151-8; PMID: 21130657; http://dx.doi.org/10.1016/j.tibs.2010.11.001
   PubMed Web of Science ®Google Scholar
• Uptain SM, Lindquist S. Prions as protein-based genetic elements. Annu Rev Microbiol 2002; 56:703-41; PMID: 12142498; http://dx.doi.org/10.1146/annurev.micro.56.013002.100603
   PubMed Web of Science ®Google Scholar
• Wickner RB, Edskes HK, Shewmaker F, Nakayashiki T. Prions of fungi: inherited structures and biological roles. Nat Rev Microbiol 2007; 5:611-8; PMID: 17632572; http://dx.doi.org/10.1038/nrmicro1708
   PubMed Web of Science ®Google Scholar
• Tanaka M, Collins SR, Toyama BH, Weissman JS. The physical basis of how prion conformations determine strain phenotypes. Nature 2006; 442:585-9; PMID: 16810177; http://dx.doi.org/10.1038/nature04922
   PubMed Web of Science ®Google Scholar
• Malato L, Dos Reis S, Benkemoun L, Sabate R, Saupe SJ. Role of Hsp104 in the propagation and inheritance of the; Het-s prion. Mol Biol Cell 2007; 18:4803-12; PMID: 17881723; http://dx.doi.org/10.1091/mbc.E07-07-0657
   PubMedGoogle Scholar
• Coustou V, Deleu C, Saupe S, Begueret J. The protein product of the het-s heterokaryon incompatibility gene of the fungus Podospora anserina behaves as a prion analog. Proc Natl Acad Sci U S A 1997; 94:9773-8; PMID: 9275200; http://dx.doi.org/10.1073/pnas.94.18.9773
   PubMed Web of Science ®Google Scholar
• Maddelein ML, Dos Reis S, Duvezin-Caubet S, Coulary-Salin B, Saupe SJ. Amyloid aggregates of the HET-s prion protein are infectious. Proc Natl Acad Sci U S A 2002; 99:7402-7; PMID: 12032295; http://dx.doi.org/10.1073/pnas.072199199
   PubMed Web of Science ®Google Scholar
• Nazabal A, Dos Reis S, Bonneu M, Saupe SJ, Schmitter JM. Conformational transition occurring upon amyloid aggregation of the HET-s prion protein of Podospora anserina analyzed by hydrogen/deuterium exchange and mass spectrometry. Biochemistry 2003; 42:8852-61; PMID: 12873146; http://dx.doi.org/10.1021/bi0344275
   PubMed Web of Science ®Google Scholar
• Mathur V, Seuring C, Riek R, Saupe SJ, Liebman SW. Localization of HET-S to the cell periphery, not to; het-s aggregates, is associated with; het-s-HET-S toxicity. Mol Cell Biol 2012; 32:139-53; PMID: 22037764; http://dx.doi.org/10.1128/MCB.06125-11
   PubMed Web of Science ®Google Scholar
• Greenwald J, Buhtz C, Ritter C, Kwiatkowski W, Choe S, Maddelein ML, Ness F, Cescau S, Soragni A, Leitz D, et al. The mechanism of prion inhibition by HET-S. Mol Cell 2010; 38:889-99; PMID: 20620958; http://dx.doi.org/10.1016/j.molcel.2010.05.019
   PubMed Web of Science ®Google Scholar
• Balguerie A, Dos Reis S, Ritter C, Chaignepain S, Coulary-Salin B, Forge V, Bathany K, Lascu I, Schmitter JM, Riek R, et al. Domain organization and structure-function relationship of the HET-s prion protein of Podospora anserina. EMBO J 2003; 22:2071-81; PMID: 12727874; http://dx.doi.org/10.1093/emboj/cdg213
   PubMed Web of Science ®Google Scholar
• Seuring C, Greenwald J, Wasmer C, Wepf R, Saupe SJ, Meier BH, Riek R. The mechanism of toxicity in HET-S/HET-s prion incompatibility. PLoS Biol 2012; 10:e1001451; PMID: 23300377; http://dx.doi.org/10.1371/journal.pbio.1001451
   PubMed Web of Science ®Google Scholar
• Dueholm MS, Albertsen M, Otzen D, Nielsen PH. Curli functional amyloid systems are phylogenetically widespread and display large diversity in operon and protein structure. PLoS One 2012; 7:e51274; PMID: 23251478; http://dx.doi.org/10.1371/journal.pone.0051274
   PubMedGoogle Scholar
• Sawyer EB, Claessen D, Haas M, Hurgobin B, Gras SL. The assembly of individual chaplin peptides from Streptomyces coelicolor into functional amyloid fibrils. PLoS One 2011; 6:e18839; PMID: 21526199; http://dx.doi.org/10.1371/journal.pone.0018839
   PubMed Web of Science ®Google Scholar
• Oli MW, Otoo HN, Crowley PJ, Heim KP, Nascimento MM, Ramsook CB, Lipke PN, Brady LJ. Functional amyloid formation by Streptococcus mutans. Microbiology 2012; 158:2903-16; PMID: 23082034; http://dx.doi.org/10.1099/mic.0.060855-0
   PubMedGoogle Scholar
• Schwartz K, Syed AK, Stephenson RE, Rickard AH, Boles BR. Functional amyloids composed of phenol soluble modulins stabilize Staphylococcus aureus biofilms. PLoS Pathog 2012; 8:e1002744; PMID: 22685403; http://dx.doi.org/10.1371/journal.ppat.1002744
   PubMed Web of Science ®Google Scholar
• Kwan AH, Winefield RD, Sunde M, Matthews JM, Haverkamp RG, Templeton MD, Mackay JP. Structural basis for rodlet assembly in fungal hydrophobins. Proc Natl Acad Sci U S A 2006; 103:3621-6; PMID: 16537446; http://dx.doi.org/10.1073/pnas.0505704103
   PubMed Web of Science ®Google Scholar
• Alberti S, Halfmann R, King O, Kapila A, Lindquist S. A systematic survey identifies prions and illuminates sequence features of prionogenic proteins. Cell 2009; 137:146-58; PMID: 19345193; http://dx.doi.org/10.1016/j.cell.2009.02.044
   PubMed Web of Science ®Google Scholar
• Kenney JM, Knight D, Wise MJ, Vollrath F. Amyloidogenic nature of spider silk. Eur J Biochem 2002; 269:4159-63; PMID: 12180993; http://dx.doi.org/10.1046/j.1432-1033.2002.03112.x
   PubMedGoogle Scholar
• Iconomidou VA, Vriend G, Hamodrakas SJ. Amyloids protect the silkmoth oocyte and embryo. FEBS Lett 2000; 479:141-5; PMID: 10981723; http://dx.doi.org/10.1016/S0014-5793(00)01888-3
   PubMed Web of Science ®Google Scholar
• Si K, Lindquist S, Kandel ER. A neuronal isoform of the aplysia CPEB has prion-like properties. Cell 2003; 115:879-91; PMID: 14697205; http://dx.doi.org/10.1016/S0092-8674(03)01020-1
   PubMed Web of Science ®Google Scholar
• Fowler DM, Koulov AV, Alory-Jost C, Marks MS, Balch WE, Kelly JW. Functional amyloid formation within mammalian tissue. PLoS Biol 2006; 4:e6; PMID: 16300414; http://dx.doi.org/10.1371/journal.pbio.0040006
   PubMed Web of Science ®Google Scholar
• Whelly S, Johnson S, Powell J, Borchardt C, Hastert MC, Cornwall GA. Nonpathological extracellular amyloid is present during normal epididymal sperm maturation. PLoS One 2012; 7:e36394; PMID: 22570708; http://dx.doi.org/10.1371/journal.pone.0036394
   PubMed Web of Science ®Google Scholar
• Maji SK, Perrin MH, Sawaya MR, Jessberger S, Vadodaria K, Rissman RA, Singru PS, Nilsson KP, Simon R, Schubert D, et al. Functional amyloids as natural storage of peptide hormones in pituitary secretory granules. Science 2009; 325:328-32; PMID: 19541956; http://dx.doi.org/10.1126/science.1173155
   PubMed Web of Science ®Google Scholar
• Lashuel HA, Lansbury PT, Jr. Are amyloid diseases caused by protein aggregates that mimic bacterial pore-forming toxins? Q Rev Biophys 2006; 39:167-201; PMID: 16978447; http://dx.doi.org/10.1017/S0033583506004422
   PubMed Web of Science ®Google Scholar
• Chapman MR, Robinson LS, Pinkner JS, Roth R, Heuser J, Hammar M, Normark S, Hultgren SJ. Role of Escherichia coli curli operons in directing amyloid fiber formation. Science 2002; 295:851-5; PMID: 11823641; http://dx.doi.org/10.1126/science.1067484
   PubMed Web of Science ®Google Scholar
• Barnhart MM, Chapman MR. Curli biogenesis and function. Annu Rev Microbiol 2006; 60:131-47; PMID: 16704339; http://dx.doi.org/10.1146/annurev.micro.60.080805.142106
   PubMed Web of Science ®Google Scholar
• Villar-Pique A, Espargaro A, Sabate R, de Groot NS, Ventura S. Using bacterial inclusion bodies to screen for amyloid aggregation inhibitors. Microb Cell Fact 2012; 11:55; PMID: 22553999; http://dx.doi.org/10.1186/1475-2859-11-55
   PubMed Web of Science ®Google Scholar
• McGlinchey RP, Kryndushkin D, Wickner RB. Suicidal; PSI+ is a lethal yeast prion. Proc Natl Acad Sci U S A 2011; 108:5337-41; PMID: 21402947; http://dx.doi.org/10.1073/pnas.1102762108
   PubMed Web of Science ®Google Scholar
• Wickner RB, Edskes HK, Bateman D, Kelly AC, Gorkovskiy A. The yeast prions; PSI+ and; URE3 are molecular degenerative diseases. Prion 2011; 5:258-62; PMID: 22052353; http://dx.doi.org/10.4161/pri.17748
   PubMed Web of Science ®Google Scholar
• Halfmann R, Jarosz DF, Jones SK, Chang A, Lancaster AK, Lindquist S. Prions are a common mechanism for phenotypic inheritance in wild yeasts. Nature 2012; 482:363-8; PMID: 22337056; http://dx.doi.org/10.1038/nature10875
   PubMed Web of Science ®Google Scholar
• Jensen MA, True HL, Chernoff YO, Lindquist S. Molecular population genetics and evolution of a prion-like protein in Saccharomyces cerevisiae. Genetics 2001; 159:527-35; PMID: 11606530
   PubMed Web of Science ®Google Scholar
• Eaglestone SS, Cox BS, Tuite MF. Translation termination efficiency can be regulated in Saccharomyces cerevisiae by environmental stress through a prion-mediated mechanism. EMBO J 1999; 18:1974-81; PMID: 10202160; http://dx.doi.org/10.1093/emboj/18.7.1974
   PubMed Web of Science ®Google Scholar
• True HL, Berlin I, Lindquist SL. Epigenetic regulation of translation reveals hidden genetic variation to produce complex traits. Nature 2004; 431:184-7; PMID: 15311209; http://dx.doi.org/10.1038/nature02885
   PubMed Web of Science ®Google Scholar
• True HL, Lindquist SL. A yeast prion provides a mechanism for genetic variation and phenotypic diversity. Nature 2000; 407:477-83; PMID: 11028992; http://dx.doi.org/10.1038/35035005
   PubMed Web of Science ®Google Scholar
• Namy O, Galopier A, Martini C, Matsufuji S, Fabret C, Rousset JP. Epigenetic control of polyamines by the prion; PSI+. Nat Cell Biol 2008; 10:1069-75; PMID: 19160487; http://dx.doi.org/10.1038/ncb1766
   PubMedGoogle Scholar
• Lancaster AK, Bardill JP, True HL, Masel J. The spontaneous appearance rate of the yeast prion; PSI+ and its implications for the evolution of the evolvability properties of the; PSI+ system. Genetics 2010; 184:393-400; PMID: 19917766; http://dx.doi.org/10.1534/genetics.109.110213
   PubMed Web of Science ®Google Scholar
• Shewmaker F, Mull L, Nakayashiki T, Masison DC, Wickner RB. Ure2p function is enhanced by its prion domain in Saccharomyces cerevisiae. Genetics 2007; 176:1557-65; PMID: 17507672; http://dx.doi.org/10.1534/genetics.107.074153
   PubMed Web of Science ®Google Scholar
• Cheon M, Chang I, Mohanty S, Luheshi LM, Dobson CM, Vendruscolo M, Favrin G. Structural reorganisation and potential toxicity of oligomeric species formed during the assembly of amyloid fibrils. PLoS Comput Biol 2007; 3:1727-38; PMID: 17941703
   PubMed Web of Science ®Google Scholar
• Necula M, Kayed R, Milton S, Glabe CG. Small molecule inhibitors of aggregation indicate that amyloid beta oligomerization and fibrillization pathways are independent and distinct. J Biol Chem 2007; 282:10311-24; PMID: 17284452; http://dx.doi.org/10.1074/jbc.M608207200
   PubMed Web of Science ®Google Scholar
• Sakono M, Zako T. Amyloid oligomers: formation and toxicity of Abeta oligomers. FEBS J 2010; 277:1348-58; PMID: 20148964; http://dx.doi.org/10.1111/j.1742-4658.2010.07568.x
   PubMed Web of Science ®Google Scholar
• Brandner S, Isenmann S, Kuhne G, Aguzzi A. Identification of the end stage of scrapie using infected neural grafts. Brain Pathol 1998; 8:19-27; PMID: 9458163; http://dx.doi.org/10.1111/j.1750-3639.1998.tb00130.x
   PubMedGoogle Scholar
• Brandner S, Isenmann S, Raeber A, Fischer M, Sailer A, Kobayashi Y, Marino S, Weissmann C, Aguzzi A. Normal host prion protein necessary for scrapie-induced neurotoxicity. Nature 1996; 379:339-43; PMID: 8552188; http://dx.doi.org/10.1038/379339a0
   PubMed Web of Science ®Google Scholar
• Novitskaya V, Bocharova OV, Bronstein I, Baskakov IV. Amyloid fibrils of mammalian prion protein are highly toxic to cultured cells and primary neurons. J Biol Chem 2006; 281:13828-36; PMID: 16554307; http://dx.doi.org/10.1074/jbc.M511174200
   PubMed Web of Science ®Google Scholar
• Simoneau S, Rezaei H, Sales N, Kaiser-Schulz G, Lefebvre-Roque M, Vidal C, Fournier JG, Comte J, Wopfner F, Grosclaude J, et al. In vitro and in vivo neurotoxicity of prion protein oligomers. PLoS Pathog 2007; 3:e125; PMID: 17784787; http://dx.doi.org/10.1371/journal.ppat.0030125
   PubMed Web of Science ®Google Scholar
• Silveira JR, Raymond GJ, Hughson AG, Race RE, Sim VL, Hayes SF, Caughey B. The most infectious prion protein particles. Nature 2005; 437:257-61; PMID: 16148934; http://dx.doi.org/10.1038/nature03989
   PubMed Web of Science ®Google Scholar
• Hill AF, Antoniou M, Collinge J. Protease-resistant prion protein produced in vitro lacks detectable infectivity. J Gen Virol 1999; 80 (Pt 1):11-4; PMID: 9934677
   PubMed Web of Science ®Google Scholar
• Sandberg MK, Al-Doujaily H, Sharps B, Clarke AR, Collinge J. Prion propagation and toxicity in vivo occur in two distinct mechanistic phases. Nature 2011; 470:540-2; PMID: 21350487; http://dx.doi.org/10.1038/nature09768
   PubMed Web of Science ®Google Scholar
• Collinge J, Clarke AR. A general model of prion strains and their pathogenicity. Science 2007; 318:930-6; PMID: 17991853; http://dx.doi.org/10.1126/science.1138718
   PubMed Web of Science ®Google Scholar
• Zhou M, Ottenberg G, Sferrazza GF, Lasmezas CI. Highly neurotoxic monomeric alpha-helical prion protein. Proc Natl Acad Sci U S A 2012; 109:3113-8; PMID: 22323583; http://dx.doi.org/10.1073/pnas.1118090109
   PubMedGoogle Scholar
• Zhang B, Une Y, Fu X, Yan J, Ge F, Yao J, Sawashita J, Mori M, Tomozawa H, Kametani F, et al. Fecal transmission of AA amyloidosis in the cheetah contributes to high incidence of disease. Proc Natl Acad Sci U S A 2008; 105:7263-8; PMID: 18474855; http://dx.doi.org/10.1073/pnas.0800367105
   PubMed Web of Science ®Google Scholar
• Korenaga T, Yan J, Sawashita J, Matsushita T, Naiki H, Hosokawa M, Mori M, Higuchi K, Fu X. Transmission of amyloidosis in offspring of mice with AApoAII amyloidosis. Am J Pathol 2006; 168:898-906; PMID: 16507905; http://dx.doi.org/10.2353/ajpath.2006.050350
   PubMedGoogle Scholar
• Desplats P, Lee HJ, Bae EJ, Patrick C, Rockenstein E, Crews L, Spencer B, Masliah E, Lee SJ. Inclusion formation and neuronal cell death through neuron-to-neuron transmission of alpha-synuclein. Proc Natl Acad Sci U S A 2009; 106:13010-5; PMID: 19651612; http://dx.doi.org/10.1073/pnas.0903691106
   PubMed Web of Science ®Google Scholar
• Freundt EC, Maynard N, Clancy EK, Roy S, Bousset L, Sourigues Y, Covert M, Melki R, Kirkegaard K, Brahic M. Neuron-to-neuron transmission of alpha-synuclein fibrils through axonal transport. Ann Neurol 2012; 72:517-24; PMID: 23109146; http://dx.doi.org/10.1002/ana.23747
   PubMed Web of Science ®Google Scholar
• Reyes JF, Rey NL, Bousset L, Melki R, Brundin P, Angot E. Alpha-synuclein transfers from neurons to oligodendrocytes. Glia 2014; 62:387-98; PMID: 24382629; http://dx.doi.org/10.1002/glia.22611
   PubMed Web of Science ®Google Scholar
• Karpinar DP, Balija MB, Kugler S, Opazo F, Rezaei-Ghaleh N, Wender N, Kim HY, Taschenberger G, Falkenburger BH, Heise H, et al. Pre-fibrillar alpha-synuclein variants with impaired beta-structure increase neurotoxicity in Parkinson's disease models. EMBO J 2009; 28:3256-68; PMID: 19745811; http://dx.doi.org/10.1038/emboj.2009.257
   PubMed Web of Science ®Google Scholar
• Periquet M, Fulga T, Myllykangas L, Schlossmacher MG, Feany MB. Aggregated alpha-synuclein mediates dopaminergic neurotoxicity in vivo. J Neurosci 2007; 27:3338-46; PMID: 17376994; http://dx.doi.org/10.1523/JNEUROSCI.0285-07.2007
   PubMed Web of Science ®Google Scholar
• Taschenberger G, Garrido M, Tereshchenko Y, Bahr M, Zweckstetter M, Kugler S. Aggregation of alphaSynuclein promotes progressive in vivo neurotoxicity in adult rat dopaminergic neurons. Acta Neuropathol 2012; 123:671-83; PMID: 22167382; http://dx.doi.org/10.1007/s00401-011-0926-8
   PubMedGoogle Scholar
• Roostaee A, Beaudoin S, Staskevicius A, Roucou X. Aggregation and neurotoxicity of recombinant alpha-synuclein aggregates initiated by dimerization. Mol Neurodegener 2013; 8:5; PMID: 23339399; http://dx.doi.org/10.1186/1750-1326-8-5
   PubMedGoogle Scholar
• El-Agnaf OM, Salem SA, Paleologou KE, Cooper LJ, Fullwood NJ, Gibson MJ, Curran MD, Court JA, Mann DM, Ikeda S, et al. Alpha-synuclein implicated in Parkinson's disease is present in extracellular biological fluids, including human plasma. FASEB J 2003; 17:1945-7; PMID: 14519670
   PubMed Web of Science ®Google Scholar
• de Silva R, Farrer M. Tau neurotoxicity without the lesions: a fly challenges a tangled web. Trends Neurosci 2002; 25:327-9; PMID: 12079751; http://dx.doi.org/10.1016/S0166-2236(02)02170-7
   PubMedGoogle Scholar
• Bates G. Huntingtin aggregation and toxicity in Huntington's disease. Lancet 2003; 361:1642-4; PMID: 12747895; http://dx.doi.org/10.1016/S0140-6736(03)13304-1
   PubMed Web of Science ®Google Scholar
• Farias G, Cornejo A, Jimenez J, Guzman L, Maccioni RB. Mechanisms of tau self-aggregation and neurotoxicity. Curr Alzheimer Res 2011; 8:608-14; PMID: 21605046; http://dx.doi.org/10.2174/156720511796717258
   PubMed Web of Science ®Google Scholar
• Ashe KH, Zahs KR. Probing the biology of Alzheimer's disease in mice. Neuron 2010; 66:631-45; PMID: 20547123; http://dx.doi.org/10.1016/j.neuron.2010.04.031
   PubMed Web of Science ®Google Scholar
• Lasagna-Reeves CA, Castillo-Carranza DL, Sengupta U, Clos AL, Jackson GR, Kayed R. Tau oligomers impair memory and induce synaptic and mitochondrial dysfunction in wild-type mice. Mol Neurodegener 2011; 6:39; PMID: 21645391; http://dx.doi.org/10.1186/1750-1326-6-39
   PubMed Web of Science ®Google Scholar
• Nucifora LG, Burke KA, Feng X, Arbez N, Zhu S, Miller J, Yang G, Ratovitski T, Delannoy M, Muchowski PJ, et al. Identification of novel potentially toxic oligomers formed in vitro from mammalian-derived expanded huntingtin exon-1 protein. J Biol Chem 2012; 287:16017-28; PMID: 22433867; http://dx.doi.org/10.1074/jbc.M111.252577
   PubMed Web of Science ®Google Scholar
• Nekooki-Machida Y, Kurosawa M, Nukina N, Ito K, Oda T, Tanaka M. Distinct conformations of in vitro and in vivo amyloids of huntingtin-exon1 show different cytotoxicity. Proc Natl Acad Sci U S A 2009; 106:9679-84; PMID: 19487684; http://dx.doi.org/10.1073/pnas.0812083106
   PubMed Web of Science ®Google Scholar
• Le MN, Kim W, Lee S, McKee AC, Hall GF. Multiple mechanisms of extracellular tau spreading in a non-transgenic tauopathy model. Am J Neurodegener Dis 2012; 1:316-33; PMID: 23383401
   PubMedGoogle Scholar
• Langer F, Eisele YS, Fritschi SK, Staufenbiel M, Walker LC, Jucker M. Soluble Abeta seeds are potent inducers of cerebral beta-amyloid deposition. J Neurosci 2011; 31:14488-95; PMID: 21994365; http://dx.doi.org/10.1523/JNEUROSCI.3088-11.2011
   PubMed Web of Science ®Google Scholar
• Stohr J, Watts JC, Mensinger ZL, Oehler A, Grillo SK, DeArmond SJ, Prusiner SB, Giles K. Purified and synthetic Alzheimer's amyloid beta (Abeta) prions. Proc Natl Acad Sci U S A 2012; 109:11025-30; PMID: 22711819; http://dx.doi.org/10.1073/pnas.1206555109
   PubMed Web of Science ®Google Scholar
• Ono K, Condron MM, Teplow DB. Structure-neurotoxicity relationships of amyloid beta-protein oligomers. Proc Natl Acad Sci U S A 2009; 106:14745-50; PMID: 19706468; http://dx.doi.org/10.1073/pnas.0905127106
   PubMed Web of Science ®Google Scholar
• Choi YJ, Chae S, Kim JH, Barald KF, Park JY, Lee SH. Neurotoxic amyloid beta oligomeric assemblies recreated in microfluidic platform with interstitial level of slow flow. Sci Rep 2013; 3:1921; PMID: 23719665
   PubMedGoogle Scholar
• Rijal Upadhaya A, Capetillo-Zarate E, Kosterin I, Abramowski D, Kumar S, Yamaguchi H, Walter J, Fändrich M, Staufenbiel M, Thal DR. Dispersible amyloid beta-protein oligomers, protofibrils, and fibrils represent diffusible but not soluble aggregates: their role in neurodegeneration in amyloid precursor protein (APP) transgenic mice. Neurobiol Aging 2012; 33:2641-60; PMID: 22305478; http://dx.doi.org/10.1016/j.neurobiolaging.2011.12.032
   PubMed Web of Science ®Google Scholar
• Sabate R, Espargaro A, Barbosa-Barros L, Ventura S, Estelrich J. Effect of the surface charge of artificial model membranes on the aggregation of amyloid beta-peptide. Biochimie 2012; 94:1730-8; PMID: 22542639; http://dx.doi.org/10.1016/j.biochi.2012.03.027
   PubMedGoogle Scholar